🇺🇸 FDA
Patent

US 8383669

Crystalline form of a 3-phenoxymethylpyrrolidine compound

granted A61KA61K31/40A61K45/06

Quick answer

US patent 8383669 (Crystalline form of a 3-phenoxymethylpyrrolidine compound) held by Theravance, Inc. expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/40, A61K45/06, A61P, A61P13/00